Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate hearing spotlights rising harms tied to concentrated 7‑hydroxymitragynine and enforcement limits
Summary
Health officials and county medical examiners told the Senate Health Committee that concentrated 7‑hydroxymitragynine (7OH) products are linked to a recent rise in unexplained deaths and that gaps in testing and enforcement hinder efforts to remove dangerous products from retail shelves.
A California Senate Health Committee informational hearing on kratom and 7‑hydroxymitragynine (7OH) on July 30, 2025 brought clinicians, state and county health officials, and a medical examiner together to outline a pattern of severe harms tied to concentrated 7OH products and to describe limits in testing and enforcement.
Officials from the California Department of Public Health said the department’s review of death records identified 362 kratom‑related overdose deaths statewide from 2019 through 2023 and 15 death certificates that specifically listed 7OH as a contributing substance. Maral Farsi, speaking for the department, said those figures are likely undercounts because they were identified through text searches of death certificates and that differentiation between unmodified…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
